Research output per year
Research output per year
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Anticipated barriers and facilitators for implementing smart inhalers in asthma medication adherence management
van de Hei, S. J., Stoker, N., Flokstra-de Blok, B. M. J., Poot, C. C., Meijer, E., Postma, M. J., Chavannes, N. H., Kocks, J. W. H. & van Boven, J. F. M., 20-May-2023, In: npj Primary Care Respiratory Medicine. 33, 10 p., 22.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile1 Citation (Scopus)8 Downloads (Pure) -
Clinical and economic burden of drug-susceptible tuberculosis in Indonesia: national trends 2017-19
Iskandar, D., Suwantika, A. A., Pradipta, I. S., Postma, M. J. & van Boven, J. F. M., 3-Jan-2023, In: The Lancet Global Health. 11, 1, p. 117-125 9 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile2 Citations (Scopus)82 Downloads (Pure) -
Clinical pharmacy services for tuberculosis management: a systematic review
Iskandar, D., Suryanegara, F. D. A., van Boven, J. F. M. & Postma, M. J., 7-Jul-2023, In: Frontiers in Pharmacology. 14, 16 p., 1186905.Research output: Contribution to journal › Review article › peer-review
Open AccessFile12 Downloads (Pure) -
Correction to: "Cost-effectiveness of ACL treatment is dependent on age and activity level: a systematic review"
Deviandri, R., van der Veen, H. C., Lubis, A. M. T., van den Akker-Scheek, I. & Postma, M. J., Feb-2023, In: Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA. 31, 2, p. 542Research output: Contribution to journal › Erratum
Open Access -
Cost-effectiveness model of trastuzumab deruxtecan as second-line treatment in HER2-positive unresectable and/or metastatic breast cancer in Finland
Paulissen, J. H. J., Seddik, A. H., Dunton, K. J., Livings, C. J., van Hulst, M., Postma, M. J., de Jong, L. A. & Freriks, R. D., 2023, (E-pub ahead of print) In: European Journal of Health Economics.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile
-
The Lancet Global Health (Journal)
Maarten Postma (Peer reviewer)
2018Activity: Peer-review and editorial work › Editorial work › Academic
-
Member of Expert Roster World Health Organization (WHO)
Maarten Postma (Advisor)
2018Activity: External assignment › Consultancy › Professional
-
The Full Public Health Value of Vaccines
Maarten Postma (Organiser)
3-Dec-2018 → 7-Dec-2018Activity: Organising and attending an event › Organising and contributing to an event › Academic
-
Workshop FarmacoEconomie
Maarten Postma (Invited speaker)
2-Feb-2018Activity: Talk and presentation › Professional or public presentation › Professional
-
Invited lecture at PharmAccess Workshop, London
Maarten Postma (Invited speaker)
Apr-2018Activity: Talk and presentation › Academic presentation › Academic
Datasets
-
Economic analyses of respiratory tract infection diagnostics: a systematic review
van der Pol, S. (Creator), Rojas Garcia, P. (Creator), Postma, M. (Creator), Villar, F. A. (Creator) & van Asselt, T. (Creator), University of Groningen, 16-May-2021
DOI: 10.5281/zenodo.4765619, https://github.com/UMCG-Global-Health/VALUE-Dx-systematic-review
Dataset
-
Additional file 2 of School health in Europe: a review of workforce expenditure across five countries
van der Pol, S. (Contributor), Postma, M. (Contributor) & Jansen, D. (Contributor), figshare, 13-Mar-2020
DOI: 10.6084/m9.figshare.11979231.v1
Dataset
-
Ulipristal acetate for pre-operative treatment of moderate to severe uterine fibroids in women of reproductive age in The Netherlands: cost minimization analysis and budget impact analysis
van Asselt, T. (Contributor), Postma, M. (Contributor) & Zakiyah, N. (Contributor), University of Groningen, 27-Oct-2016
DOI: 10.6084/m9.figshare.4106286.v1, https://doi.org/10.6084%2Fm9.figshare.4106286.v1
Dataset
-
Cost-effectiveness analysis of rivaroxaban for treatment and secondary prevention of venous thromboembolism in the Netherlands
Heisen, M. (Contributor), Treur, M. J. (Contributor), Heemstra, H. E. (Contributor), Giesen, E. B. W. (Contributor) & Postma, M. (Contributor), University of Groningen, 19-May-2017
DOI: 10.6084/m9.figshare.5024366.v1
Dataset
-
Data from: Cost-minimization model of a multidisciplinary antibiotic stewardship team based on a successful implementation on a urology ward of an academic hospital
Dik, J. (Creator), Hendrix, R. (Creator), Friedrich, A. (Creator), Luttjeboer, J. (Creator), Nannan Panday, P. (Creator), Wilting, K. R. (Creator), Lo-Ten-Foe, J. R. (Creator), Postma, M. (Creator) & Sinha, B. (Creator), University of Groningen, 8-May-2015
DOI: 10.5061/dryad.kq2r1
Dataset
Press/Media
-
Dat meningokokken-vaccin is echt niet te duur, neem het dus op in het programma
15/02/2023
1 Media contribution
Press/Media: Expert Comment › Popular
-
Covid booster jabs: The JCVI advice on coronavirus vaccinations for autumn 2022 and who will get more vaccine
21/05/2022
1 item of Media coverage
Press/Media: Expert Comment › Popular
-
Who are the JCVI? -The group advising the government on Covid boosters
30/11/2021
2 items of Media coverage
Press/Media: Expert Comment › Popular
-
'Nederland moet meer inzetten op gebruik coronamedicijnen’
04/11/2021
1 item of Media coverage
Press/Media: Expert Comment › Popular
-
RIVM expects an ‘explosive’ flu season this winter
12/10/2021
1 item of Media coverage
Press/Media: Expert Comment › Popular